UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (70254) 70254
Newsletter (4844) 4844
Newspaper Article (690) 690
Book Chapter (530) 530
Magazine Article (131) 131
Transcript (63) 63
Conference Proceeding (35) 35
Book / eBook (31) 31
Dissertation (24) 24
Trade Publication Article (22) 22
Publication (16) 16
Web Resource (12) 12
Book Review (3) 3
Streaming Video (3) 3
Government Document (1) 1
Journal / eJournal (1) 1
Reference (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (58149) 58149
science & technology (50900) 50900
life sciences & biomedicine (47952) 47952
oncology (33949) 33949
female (30743) 30743
male (30143) 30143
middle aged (25451) 25451
aged (23926) 23926
lung neoplasms - drug therapy (23171) 23171
lung neoplasms - pathology (20843) 20843
lung cancer, non-small cell (20579) 20579
lung cancer (19369) 19369
carcinoma, non-small-cell lung - drug therapy (19204) 19204
cancer (18826) 18826
carcinoma, non-small-cell lung - pathology (16377) 16377
adult (15612) 15612
biological and medical sciences (15151) 15151
medical sciences (14964) 14964
tumors (14271) 14271
chemotherapy (13740) 13740
care and treatment (12041) 12041
prognosis (11279) 11279
research (10997) 10997
neoplasm staging (10412) 10412
antineoplastic combined chemotherapy protocols - therapeutic use (9768) 9768
cell line, tumor (9601) 9601
aged, 80 and over (9335) 9335
treatment outcome (9244) 9244
lung neoplasms - mortality (9201) 9201
non-small cell lung cancer (9017) 9017
lung neoplasms - genetics (8931) 8931
animals (8796) 8796
carcinoma, non-small-cell lung - genetics (8302) 8302
metastasis (8143) 8143
respiratory system (7478) 7478
carcinoma, non-small-cell lung - mortality (7468) 7468
antineoplastic agents (6918) 6918
lung neoplasms - therapy (6899) 6899
analysis (6877) 6877
pneumology (6872) 6872
non-small cell lung carcinoma (6793) 6793
tumors of the respiratory system and mediastinum (6697) 6697
antineoplastic agents - therapeutic use (6696) 6696
apoptosis (6568) 6568
cancer therapies (6499) 6499
mutation (6471) 6471
lung neoplasms - radiotherapy (6321) 6321
lung neoplasms - metabolism (6214) 6214
mice (6043) 6043
retrospective studies (6023) 6023
survival rate (5686) 5686
genetic aspects (5608) 5608
health aspects (5527) 5527
oncology, experimental (5468) 5468
survival analysis (5454) 5454
gene expression (5410) 5410
patients (5363) 5363
surgery (5215) 5215
carcinoma, non-small-cell lung - metabolism (5210) 5210
lung neoplasms - surgery (5165) 5165
lung cancer, small cell (5143) 5143
carcinoma, non-small-cell lung - radiotherapy (5059) 5059
pharmacology. drug treatments (5054) 5054
carcinoma, non-small-cell lung - therapy (5028) 5028
proteins (5015) 5015
combined modality therapy (5002) 5002
abridged index medicus (4630) 4630
radiotherapy (4598) 4598
cell biology (4561) 4561
carcinoma, non-small-cell lung - surgery (4548) 4548
medical prognosis (4384) 4384
hematology, oncology and palliative medicine (4351) 4351
carcinoma, small cell - drug therapy (4324) 4324
kinases (4272) 4272
medicine & public health (4226) 4226
development and progression (4085) 4085
immunohistochemistry (3891) 3891
cisplatin - administration & dosage (3848) 3848
pharmacology & pharmacy (3802) 3802
disease-free survival (3794) 3794
cell proliferation (3700) 3700
follow-up studies (3642) 3642
antineoplastic agents - pharmacology (3628) 3628
gene expression regulation, neoplastic (3538) 3538
respiratory tract diseases (3525) 3525
medicine (3521) 3521
research article (3517) 3517
nsclc (3490) 3490
small cell lung carcinoma (3347) 3347
studies (3325) 3325
lung neoplasms - diagnosis (3294) 3294
medical research (3178) 3178
antineoplastic combined chemotherapy protocols - adverse effects (3143) 3143
epidermal growth factor (3133) 3133
signal transduction (3119) 3119
radiology, nuclear medicine & medical imaging (3105) 3105
clinical trials (3083) 3083
drug therapy (3063) 3063
rna, small interfering - genetics (3059) 3059
non-small-cell lung cancer (3010) 3010
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (8) 8
Online Resources - Online (8) 8
UofT at Mississauga - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (73313) 73313
Japanese (1305) 1305
Chinese (1034) 1034
French (965) 965
German (666) 666
Russian (207) 207
Spanish (170) 170
Polish (167) 167
Italian (143) 143
Portuguese (83) 83
Hungarian (47) 47
Dutch (43) 43
Czech (35) 35
Turkish (33) 33
Danish (31) 31
Korean (31) 31
Serbian (20) 20
Norwegian (19) 19
Romanian (15) 15
Croatian (13) 13
Hebrew (10) 10
Swedish (10) 10
Finnish (9) 9
Lithuanian (5) 5
Slovak (3) 3
Ukrainian (3) 3
Bulgarian (2) 2
Icelandic (2) 2
Bosnian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 187 - 199
Journal Article
Annals of oncology, ISSN 0923-7534, 11/2018, Volume 29, Issue 11, pp. 2214 - 2222
Journal Article
2000, Lung biology in health and disease, ISBN 0824702360, Volume 140., xx, 472
Book
The New England journal of medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 829 - 838
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Central Nervous System Neoplasms - secondary | Young Adult | Pyridines - adverse effects | Anaplastic Lymphoma Kinase | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Pyrazoles - adverse effects | Pyridines - therapeutic use | Crizotinib | Carbazoles - adverse effects | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Animals | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Intention to Treat Analysis | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Central Nervous System Neoplasms - drug therapy | Drugs | Care and treatment | Analysis | Comparative analysis | Lung cancer, Non-small cell | Health aspects | Systemic diseases | Toxicity | Lung cancer | Central nervous system | Non-small cell lung carcinoma | Oncology | Nervous system | Metastasis | Radiation therapy | Patients | Lymphoma | Cancer therapies | Survival | Mutation | Protein-tyrosine kinase | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Nature communications, ISSN 2041-1723, 2015, Volume 6, Issue 1, pp. 6377 - 6377
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 07/2017, Volume 77, Issue 13, pp. 3540 - 3550
Life Sciences & Biomedicine | Oncology | Science & Technology | Gene Expression - drug effects | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Squamous Cell Carcinoma of Head and Neck | Melanoma - genetics | Gene Expression - immunology | Aged, 80 and over | Adult | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Non-Small-Cell Lung - genetics | Head and Neck Neoplasms - drug therapy | Gene Expression Profiling - methods | Melanoma - pathology | Head and Neck Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - immunology | Lung Neoplasms - immunology | Carcinoma, Squamous Cell - drug therapy | Melanoma - immunology | Melanoma - drug therapy | Nivolumab | Head and Neck Neoplasms - genetics | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Programmed Cell Death 1 Receptor - immunology | Programmed Cell Death 1 Receptor - genetics | PD-1 protein | CD8 antigen | Antibodies | Lymphocytes T | Killer cells | Cell activation | Lymphocytes | Natural killer cells | Signatures | Immune system | Squamous cell carcinoma | Head | Immune response | Small cell lung carcinoma | Tumor-infiltrating lymphocytes | Melanoma | Lung carcinoma | Gene expression | Ribonucleic acid--RNA | Patients | CD4 antigen | Immune checkpoint | Reproducibility | PD-L1 protein | Biomarkers | Head and neck cancer | Interferon | Solid tumors | Cancer | Tumors | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 11/2019, Volume 381, Issue 21, pp. 2020 - 2031
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1236 - 1244
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4, pp. 278 - 285
Journal Article